Back to top

Analyst Blog

We maintain our recommendation on Quality Systems (QSII - Analyst Report) at Neutral. Quality Systems reported second quarter fiscal 2013 (ended September 30) adjusted earnings per share of 26 cents. It missed the Zacks Consensus Estimate by 2 cents and fell short of the year-ago earnings of 35 cents per share.

Net income in the second quarter was $15.7 million, down 23% on a year-over-year basis, primarily due to declining software license sales.

Revenues increased 8% year over year to $116.1 million in the second quarter. The company’s revenues missed the Zacks Consensus Estimate of $118 million.

System sales amounted to $32.3 million, down roughly 15% year over year. Revenues from the two subcomponents were $23.7 million (down 25.5% year over year) from Software, Hardware and Supplies and $8.5 million (up 40% on a year-over-year basis) from Implementation and Training Services.

Revenues from Maintenance, Electronic Data Interchange Services (EDI), Revenue Cycle Management and Other Services amounted to $83.9 million, up 20.4% year over year. Segment sales are reported under four separate headings. Maintenance revenues came in at $38.7 million, up 9.9% year over year. Electronic Data Interchange Services revenues were $15 million, up 25.4% year over year. Revenue Cycle Management sales surged 30% year over year to $14.5 million and revenues from Other Services amounted to $15.6 million, up 38% year over year.

Quality Systems runs a pure-play business model in an attractive industry with a large number of catalysts, which provoke frequent speculation about mergers and acquisitions. On the positive side, we observe the high proportion of recurring revenues. Of late, however, its pipeline metric has been on a falling trend.

The company has made multiple acquisitions to bolster organic growth. Its acquisitions are expected to facilitate its entry in the small hospital segment. We are concerned about execution risk emanating from Quality Systems’ entry into the rural inpatient market.

Moreover, competition is intense from well regarded players such as Athenahealth (ATHN - Analyst Report), Allscripts Healthcare Solutions (MDRX - Analyst Report), Cerner Corporation (CERN - Analyst Report) and others. Price discounting is frequent, particularly at the lower end, and Software as a Service (SaaS) based model appears to have exacerbated pricing pressure.

Quality Systems has traditionally focused on providing solutions for physician practices. However, core ambulatory EHR providers such as Quality Systems will see opportunities for product sales shrink, as physician groups are increasingly absorbed into hospitals.

We have a long-term Neutral recommendation on the stock which carries a short-term Zacks #3 Rank (Hold).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
ERBA DIAGNO… ERB 3.00 +3.09%
SANCHEZ ENE… SN 34.18 +2.67%
THE PANTRY… PTRY 21.02 +2.09%
INTEL CP INTC 35.15 +1.88%
PIPER JAFFR… PJC 54.54 +1.70%